Peng, Y., Lin, C., Hsu, W., Lu, I., Yeh, H., Chang, C., & Kao, C. (2018). Proton Pump Inhibitor Use is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study. Dose Response.
Chicago Stili AlıntıPeng, Yen-Chun, Cheng-Li Lin, Wan-Yun Hsu, I-Ta Lu, Hong-Zen Yeh, Chi-Sen Chang, ve Chia-Hung Kao. "Proton Pump Inhibitor Use Is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study." Dose Response 2018.
MLA AlıntıPeng, Yen-Chun, et al. "Proton Pump Inhibitor Use Is Associated With Risk of Pancreatic Cancer: A Nested Case–Control Study." Dose Response 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..